Relative efficacy and safety of ticagelor vs clopidogrel as a function of time to invasive management in non–ST‐segment elevation acute coronary syndrome in the PLATO trial

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Clinical Cardiology

• Publication date

  2017-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/clc.22733PMID 28598510PMCID PMC6490557
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Relative efficacy and safety of ticagelor vs clopidogrel as a function of time to invasive management in non–ST‐segment elevation acute coronary syndrome in the PLATO trial

  2017cited by this paper
• Association of spontaneous and procedure-related bleeds with short- and long-term mortality after acute coronary syndromes: an analysis from the PLATO trial.

  2015cited by this paper
• Ticagrelor vs. clopidogrel in patients with non-ST-elevation acute coronary syndrome with or without revascularization: results from the PLATO trial

  2014cited by this paper
• Effect of prasugrel pre-treatment strategy in patients undergoing percutaneous coronary intervention for NSTEMI: the ACCOAST-PCI study.

  2014cited by this paper
• 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

  2014cited by this paper
• ED administration of thienopyridines in non-ST-segment elevation myocardial infarction: results from the NCDR.

  2013cited by this paper
• 2012 ACCF/AHA focused update of the guideline for the management of patients with unstable angina/non-ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Forc

  2012cited by this paper
• ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

  2011cited by this paper
• 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC).

  2011cited by this paper
• Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of Ticagrelor versus Clopidogrel in patients with stable coronary artery disease. The ONSET/OFFSET study.

  2010cited by this paper
• Ticagrelor Versus Clopidogrel in Patients With ST-Elevation Acute Coronary Syndromes Intended for Reperfusion With Primary Percutaneous Coronary Intervention: A Platelet Inhibition and Patient Outcomes (PLATO) Trial Subgroup Analysis

  2010cited by this paper
• Ticagrelor versus clopidogrel in patients with acute coronary syndromes.

  2009influential reference
• Randomized Double-Blind Assessment of the ONSET and OFFSET of the Antiplatelet Effects of Ticagrelor Versus Clopidogrel in Patients With Stable Coronary Artery Disease: The ONSET/OFFSET Study

  2009cited by this paper
• Prasugrel versus clopidogrel in patients with acute coronary syndromes.

  2007cited by this paper
• Platelet activation in myocardial ischemic syndromes

  2004cited by this paper
• ADP and platelets: the end of the beginning.

  2001cited by this paper
• EFFECTS OF CLOPIDOGREL IN ADDITION TO ASPIRIN IN PATIENTS WITH ACUTE CORONARY SYNDROMES WITHOUT ST-SEGMENT ELEVATION

  2001cited by this paper
• Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation.

  2001cited by this paper

• Ticagrelor Resistance Causing Acute In-Stent Thrombosis: Successful Management With Prasugrel and Balloon Angioplasty

  2026cites this paper
• Effect of cytochrome P450 2C19 (CYP2C19) gene polymorphism and clopidogrel reactivity on long term prognosis of patients with coronary heart disease after PCI.

  2024cites this paper
• Evolution of the prognosis of acute myocardial infarction

  2023cites this paper
• Evolution of the prognosis of acute myocardial infarction.

  2022cites this paper
• Effect of Qingre Jiedu Huoxue Huayu Recipe on blood stasis and toxin syndrome in patients with non-ST segment elevation acute coronary syndrome, serum Lp-PLA2, TNF- α, and PIGF expression level.

  2022cites this paper
• A Case of Ticagrelor Resistance.

  2021cites this paper
• Bivalirudin Versus Heparin Monotherapy in ST-Segment–Elevation Myocardial Infarction

  2021cites this paper
• Estrategias de antiagregación en síndromes coronarios agudos sin elevación del segmento ST

  2021influential citation
• Efficacy and safety of ticagrelor and clopidogrel in East Asian patients with coronary artery disease undergoing percutaneous coronary intervention

  2020cites this paper
• Subcutaneous Selatogrel Inhibits Platelet Aggregation in Patients With Acute Myocardial Infarction.

  2020cites this paper
• Efficacy and Safety of Ticagrelor and Clopidogrel in Patients with Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention

  2020cites this paper
• Oral Antiplatelet Therapy Administered Upstream to Patients With NSTEMI

  2020cites this paper
• Pre-Treatment With Oral P2Y12 Inhibitors in Acute Coronary Syndromes Without ST-Segment Elevation: The Saga Continues.

  2019cites this paper
• Contemporary NSTEMI management: the role of the hospitalist

  2019cites this paper
• Therapy with ticagrelor for ST-elevated acute coronary syndrome accompanied by diabetes mellitus.

  2019cites this paper
• Antithrombotic therapy in the early phase of NSTE-ACS: a systematic review and meta-analysis.

  2019cites this paper
• Early versus delayed invasive strategy for intermediate‐ and high‐risk acute coronary syndromes managed without P2Y12 receptor inhibitor pretreatment: Design and rationale of the EARLY randomized trial

  2018cites this paper
• Bivalirudin versus heparin monotherapy in non-ST-segment elevation myocardial infarction

  2018cites this paper
• Relative efficacy and safety of ticagelor vs clopidogrel as a function of time to invasive management in non–ST‐segment elevation acute coronary syndrome in the PLATO trial

  2017cites this paper
• Antiplatelet agents for chronic kidney disease.

  2013cites this paper